Chiropractors in Purvis, MS Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. John Robert Acord Jr., DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 105 Main Street, Purvis, MS 39475 Phone: 601-794-0081 Fax: 601-794-0083 |
 D. L. Moore & Associates, Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 121, Front St, Purvis, MS 39475 Phone: 601-749-4939 Fax: 769-301-1641 |
 Dr. Sarah O'quinn, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 105 Main St, Purvis, MS 39475 Phone: 601-348-8866 |
Purvis Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 105 Main St., Purvis, MS 39475 Phone: 601-794-0081 Fax: 601-794-0083 |
News Archive
Hospira Japan receives approval for long term use of Precedex IV sedative
Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV™200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence.
Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine
Fraunhofer USA Center for Molecular Biotechnology announced today that it has received a $4.395 million award from the Defense Advanced Research Projects Agency to develop a vaccine against H1N1 influenza virus using its plant-based production platform.
Strategies for allocating stockpiled ventilators to healthcare facilities during a pandemic
Key factors must be taken into account in determining the need for and allocation of scarce ventilators during a severe pandemic, especially one causing respiratory illness.
Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX
Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
› Verified 5 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Optometrists